药师支持进入血药浓度检验顺序,避免万古霉素所致肾损伤。

IF 3.4 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Drug Safety Pub Date : 2025-05-24 eCollection Date: 2025-01-01 DOI:10.1177/20420986251339580
Naoki Yoshikawa, Chiaki Miyata, Hidehiko Koreeda, Shuichi Nakahara, Yuki Matsusaki, Yusei Yamada, Takehiko Nagano, Hidenobu Ochiai, Ryuji Ikeda
{"title":"药师支持进入血药浓度检验顺序,避免万古霉素所致肾损伤。","authors":"Naoki Yoshikawa, Chiaki Miyata, Hidehiko Koreeda, Shuichi Nakahara, Yuki Matsusaki, Yusei Yamada, Takehiko Nagano, Hidenobu Ochiai, Ryuji Ikeda","doi":"10.1177/20420986251339580","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Task shifting and sharing have been proposed as strategies to address healthcare staffing shortages and improve patient outcomes. In emergency and intensive care medicine, pharmacist interventions have shown potential to reduce medication errors and improve care quality. However, the precise benefits of pharmacist support in therapeutic drug monitoring (TDM) for emergency center inpatients require further verification.</p><p><strong>Objective: </strong>To determine the contribution of pharmacist support in entering blood drug concentration test orders to patient safety during anti-methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) drug administration in the emergency and critical care center, and investigate the association between this support and the frequency of vancomycin-induced kidney injury.</p><p><strong>Design: </strong>Single-center retrospective cohort study comparing outcomes 2 years before and 2 years after implementing pharmacist support for blood concentration test order entry.</p><p><strong>Methods: </strong>Patients receiving intravenous vancomycin with blood concentrations measured at the emergency center were included. Propensity score matching was used to minimize confounding. The primary outcome was the change in frequency of vancomycin-induced kidney injury before and after pharmacist support implementation.</p><p><strong>Results: </strong>Pharmacist support significantly reduced the frequency of vancomycin-induced kidney injury (from 6.5% to 0.0%, <i>p</i> = 0.043) and shortened time to first TDM implementation (<i>p</i> = 0.019) in the overall cohort. Similar significant reductions were observed in the propensity score matched cohort (from 11.9% to 0.0%, <i>p</i> = 0.013).</p><p><strong>Conclusion: </strong>Pharmacist support in entering blood drug concentration test orders significantly reduced vancomycin-induced kidney injury frequency and shortened time to first TDM, enhancing patient safety during anti-MRSA medication administration in the emergency and critical care center. This task-shifting approach demonstrates clear benefits for patient care and physician workload.</p>","PeriodicalId":23012,"journal":{"name":"Therapeutic Advances in Drug Safety","volume":"16 ","pages":"20420986251339580"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103665/pdf/","citationCount":"0","resultStr":"{\"title\":\"Pharmacist support in the entry of blood drug concentration test order avoids vancomycin-induced kidney injury.\",\"authors\":\"Naoki Yoshikawa, Chiaki Miyata, Hidehiko Koreeda, Shuichi Nakahara, Yuki Matsusaki, Yusei Yamada, Takehiko Nagano, Hidenobu Ochiai, Ryuji Ikeda\",\"doi\":\"10.1177/20420986251339580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Task shifting and sharing have been proposed as strategies to address healthcare staffing shortages and improve patient outcomes. In emergency and intensive care medicine, pharmacist interventions have shown potential to reduce medication errors and improve care quality. However, the precise benefits of pharmacist support in therapeutic drug monitoring (TDM) for emergency center inpatients require further verification.</p><p><strong>Objective: </strong>To determine the contribution of pharmacist support in entering blood drug concentration test orders to patient safety during anti-methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) drug administration in the emergency and critical care center, and investigate the association between this support and the frequency of vancomycin-induced kidney injury.</p><p><strong>Design: </strong>Single-center retrospective cohort study comparing outcomes 2 years before and 2 years after implementing pharmacist support for blood concentration test order entry.</p><p><strong>Methods: </strong>Patients receiving intravenous vancomycin with blood concentrations measured at the emergency center were included. Propensity score matching was used to minimize confounding. The primary outcome was the change in frequency of vancomycin-induced kidney injury before and after pharmacist support implementation.</p><p><strong>Results: </strong>Pharmacist support significantly reduced the frequency of vancomycin-induced kidney injury (from 6.5% to 0.0%, <i>p</i> = 0.043) and shortened time to first TDM implementation (<i>p</i> = 0.019) in the overall cohort. Similar significant reductions were observed in the propensity score matched cohort (from 11.9% to 0.0%, <i>p</i> = 0.013).</p><p><strong>Conclusion: </strong>Pharmacist support in entering blood drug concentration test orders significantly reduced vancomycin-induced kidney injury frequency and shortened time to first TDM, enhancing patient safety during anti-MRSA medication administration in the emergency and critical care center. This task-shifting approach demonstrates clear benefits for patient care and physician workload.</p>\",\"PeriodicalId\":23012,\"journal\":{\"name\":\"Therapeutic Advances in Drug Safety\",\"volume\":\"16 \",\"pages\":\"20420986251339580\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103665/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20420986251339580\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20420986251339580","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:任务转移和共享已被提出作为解决医疗人员短缺和改善患者预后的策略。在急诊和重症监护医学中,药剂师的干预已显示出减少用药错误和提高护理质量的潜力。然而,药师支持对急诊中心住院患者治疗性药物监测(TDM)的确切益处需要进一步验证。目的:了解急诊重症监护中心抗甲氧西林耐药金黄色葡萄球菌(MRSA)给药过程中,药师进入血药浓度检测单的支持对患者安全的贡献,并探讨药师的支持与万古霉素肾损伤发生频率的关系。设计:单中心回顾性队列研究,比较实施药师支持血液浓度检测单输入前和后2年的结果。方法:纳入在急救中心测血药浓度并接受静脉注射万古霉素的患者。倾向评分匹配用于最小化混淆。主要观察结果是在实施药师支持前后万古霉素引起的肾损伤发生频率的变化。结果:在整个队列中,药师支持显著降低了万古霉素所致肾损伤的发生率(从6.5%降至0.0%,p = 0.043),缩短了首次实施TDM的时间(p = 0.019)。在倾向评分匹配的队列中也观察到类似的显著降低(从11.9%降至0.0%,p = 0.013)。结论:药师支持进入血药浓度试验单,可显著降低万古霉素所致肾损伤发生率,缩短首次TDM时间,提高患者在急危重症抗mrsa用药过程中的安全性。这种任务转移方法对病人护理和医生工作量有明显的好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pharmacist support in the entry of blood drug concentration test order avoids vancomycin-induced kidney injury.

Background: Task shifting and sharing have been proposed as strategies to address healthcare staffing shortages and improve patient outcomes. In emergency and intensive care medicine, pharmacist interventions have shown potential to reduce medication errors and improve care quality. However, the precise benefits of pharmacist support in therapeutic drug monitoring (TDM) for emergency center inpatients require further verification.

Objective: To determine the contribution of pharmacist support in entering blood drug concentration test orders to patient safety during anti-methicillin-resistant Staphylococcus aureus (MRSA) drug administration in the emergency and critical care center, and investigate the association between this support and the frequency of vancomycin-induced kidney injury.

Design: Single-center retrospective cohort study comparing outcomes 2 years before and 2 years after implementing pharmacist support for blood concentration test order entry.

Methods: Patients receiving intravenous vancomycin with blood concentrations measured at the emergency center were included. Propensity score matching was used to minimize confounding. The primary outcome was the change in frequency of vancomycin-induced kidney injury before and after pharmacist support implementation.

Results: Pharmacist support significantly reduced the frequency of vancomycin-induced kidney injury (from 6.5% to 0.0%, p = 0.043) and shortened time to first TDM implementation (p = 0.019) in the overall cohort. Similar significant reductions were observed in the propensity score matched cohort (from 11.9% to 0.0%, p = 0.013).

Conclusion: Pharmacist support in entering blood drug concentration test orders significantly reduced vancomycin-induced kidney injury frequency and shortened time to first TDM, enhancing patient safety during anti-MRSA medication administration in the emergency and critical care center. This task-shifting approach demonstrates clear benefits for patient care and physician workload.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety Medicine-Pharmacology (medical)
CiteScore
6.70
自引率
4.50%
发文量
31
审稿时长
9 weeks
期刊介绍: Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信